1054 related articles for article (PubMed ID: 24011636)
1. New pharmacological options for treating advanced Parkinson's disease.
Devos D; Moreau C; Dujardin K; Cabantchik I; Defebvre L; Bordet R
Clin Ther; 2013 Oct; 35(10):1640-52. PubMed ID: 24011636
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate : a treatment for Parkinson's disease?
Devos D; Moreau C; Delval A; Dujardin K; Defebvre L; Bordet R
CNS Drugs; 2013 Jan; 27(1):1-14. PubMed ID: 23160937
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease].
Devos D; Bordet R; Defebvre L
Rev Neurol (Paris); 2010 Feb; 166(2):168-77. PubMed ID: 19811797
[TBL] [Abstract][Full Text] [Related]
4. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.
Moreau C; Delval A; Defebvre L; Dujardin K; Duhamel A; Petyt G; Vuillaume I; Corvol JC; Brefel-Courbon C; Ory-Magne F; Guehl D; Eusebio A; Fraix V; Saulnier PJ; Lagha-Boukbiza O; Durif F; Faighel M; Giordana C; Drapier S; Maltête D; Tranchant C; Houeto JL; Debû B; Sablonniere B; Azulay JP; Tison F; Rascol O; Vidailhet M; Destée A; Bloem BR; Bordet R; Devos D;
Lancet Neurol; 2012 Jul; 11(7):589-96. PubMed ID: 22658702
[TBL] [Abstract][Full Text] [Related]
6. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
[TBL] [Abstract][Full Text] [Related]
7. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease.
Devos D; Defebvre L; Bordet R
Fundam Clin Pharmacol; 2010 Aug; 24(4):407-21. PubMed ID: 20163480
[TBL] [Abstract][Full Text] [Related]
9. Non-dopaminergic treatments for motor control in Parkinson's disease.
Fox SH
Drugs; 2013 Sep; 73(13):1405-15. PubMed ID: 23917951
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
[TBL] [Abstract][Full Text] [Related]
11. Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials.
Kalia LV; Brotchie JM; Fox SH
Mov Disord; 2013 Feb; 28(2):131-44. PubMed ID: 23225267
[TBL] [Abstract][Full Text] [Related]
12. [Significant improvement of motor symptoms by deep brain stimulation of bilateral subthalamic nucleus in patients with moderate or advanced Parkinson's disease].
Chen J; Liu JL; Chen X; Qian H; Xian WB; Zhou HY; Liu YM; Ye XF; Zheng YF; Zhang SL; Chen L; Li JR; Liu ZL; Pei Z
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):291-5. PubMed ID: 21419000
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.
Moreau C; Meguig S; Corvol JC; Labreuche J; Vasseur F; Duhamel A; Delval A; Bardyn T; Devedjian JC; Rouaix N; Petyt G; Brefel-Courbon C; Ory-Magne F; Guehl D; Eusebio A; Fraix V; Saulnier PJ; Lagha-Boukbiza O; Durif F; Faighel M; Giordana C; Drapier S; Maltête D; Tranchant C; Houeto JL; Debû B; Azulay JP; Tison F; Destée A; Vidailhet M; Rascol O; Dujardin K; Defebvre L; Bordet R; Sablonnière B; Devos D;
Brain; 2015 May; 138(Pt 5):1271-83. PubMed ID: 25805645
[TBL] [Abstract][Full Text] [Related]
14. Treatment of motor fluctuations in Parkinson's disease: recent developments and future directions.
Ramirez-Zamora A; Molho E
Expert Rev Neurother; 2014 Jan; 14(1):93-103. PubMed ID: 24328720
[TBL] [Abstract][Full Text] [Related]
15. Treatments for Parkinson disease--past achievements and current clinical needs.
Poewe W
Neurology; 2009 Feb; 72(7 Suppl):S65-73. PubMed ID: 19221317
[TBL] [Abstract][Full Text] [Related]
16. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Yamada K; Goto S; Hamasaki T; Kuratsu JI
Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
[TBL] [Abstract][Full Text] [Related]
17. Milestones in Parkinson's disease therapeutics.
Rascol O; Lozano A; Stern M; Poewe W
Mov Disord; 2011 May; 26(6):1072-82. PubMed ID: 21626552
[TBL] [Abstract][Full Text] [Related]
18. Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease.
Devos D; Krystkowiak P; Clement F; Dujardin K; Cottencin O; Waucquier N; Ajebbar K; Thielemans B; Kroumova M; Duhamel A; Destée A; Bordet R; Defebvre L
J Neurol Neurosurg Psychiatry; 2007 May; 78(5):470-5. PubMed ID: 17098845
[TBL] [Abstract][Full Text] [Related]
19. Deep brain stimulation and continuous dopaminergic stimulation in advanced Parkinson's disease.
Wolters ECh
Parkinsonism Relat Disord; 2007 Sep; 13 Suppl():S18-23. PubMed ID: 17702631
[TBL] [Abstract][Full Text] [Related]
20. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
Thobois S; Lhommée E; Klinger H; Ardouin C; Schmitt E; Bichon A; Kistner A; Castrioto A; Xie J; Fraix V; Pelissier P; Chabardes S; Mertens P; Quesada JL; Bosson JL; Pollak P; Broussolle E; Krack P
Brain; 2013 May; 136(Pt 5):1568-77. PubMed ID: 23543483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
